研究者
J-GLOBAL ID:202001017454947475   更新日: 2021年07月01日

成田(野田) 翔子

Noda-Narita Shoko
論文 (9件):
  • Shoko Noda-Narita, Mami Kanzaki, Yoshikazu Uesaka, Tatsuya Suwabe, Keiichi Kinowaki, Yuhji Marui, Junichi Hoshino, Naoki Sawa, Yoshifumi Ubara. Paraneoplastic Polymyositis Due to Renal Cell Carcinoma in a Patient with Autosomal Dominant Polycystic Kidney Disease. Internal medicine (Tokyo, Japan). 2021
  • Rurina Watanuki, Akihiko Shimomura, Shu Yazaki, Shoko Noda-Narita, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Tatsunori Shimoi, Emi Noguchi, et al. Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment. Medicine. 2020. 99. 38. e22331
  • Hitomi S Okuma, Kan Yonemori, Shoko N Narita, Tamie Sukigara, Akihiro Hirakawa, Toshio Shimizu, Taro Shibata, Akira Kawai, Noboru Yamamoto, Kenichi Nakamura, et al. MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial. Clinical pharmacology and therapeutics. 2020. 108. 3. 596-605
  • Shoko Noda-Narita, Akihiko Shimomura, Yuko Tanabe, Jumpei Kawauchi, Juntaro Matsuzaki, Satoko Takizawa, Yoshiaki Aoki, Chikako Shimizu, Kenji Tamura, Takahiro Ochiya. Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs. BMJ supportive & palliative care. 2020
  • Shoko Noda-Narita, Akihiko Shimomura, Asuka Kawachi, Hitomi Sumiyoshi-Okuma, Kazuki Sudo, Tatsunori Shimoi, Emi Noguchi, Kan Yonemori, Chikako Shimizu, Yasuhiro Fujiwara, et al. Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population. Breast cancer (Tokyo, Japan). 2019. 26. 4. 492-498
もっと見る
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る